Drug Discovery and Development
Scaling Cell and Gene Therapies: How AI, Automation & Workforce Trends Are Shaping Sample Management
https://www.youtube.com/watch?v=6351b_WxHOk
At the recent Cell and Gene Therapy Conference, DDD spoke with the Dr Stefan Chabierski, from ASKION about how evolving demands in the cell...
FDA approves Tecvayli plus Darzalex for relapsed/refractory multiple myeloma
Johnson & Johnson (J&J) has announced that the US Food and Drug Administration (FDA) has approved Tecvayli® (teclistamab-cqyv) plus Darzalex Faspro® (daratumumab and hyaluronidase-fihj) for the...
Tackling the mechanisms of endotoxin-induced pathogenesis
While exotoxins dominate discussions of bacterial infections, cell wall components released upon bacterial death, are equally dangerous. These endotoxins trigger hyperinflammatory responses that spiral...
FDA grants landmark hearing for Hetlioz® in jet lag disorder
Vanda Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has granted the company's request for a formal evidentiary public hearing to...
Guardant hits the road with colon cancer blood test
With colon cancer deaths rising among younger adults and millions of eligible Americans skipping their colonoscopies, Guardant Health is taking its Shield blood test...
Baricitinib recommended for approval in the European Union for adolescents with severe alopecia areata
Eli Lilly and Company and Incyte announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Olumiant (baricitinib) for...
FDA accepts license application for a treatment of generalised pustular psoriasis
The US Food and Drug Administration (FDA) has accepted the filing of a Biologics License Application (BLA) for imsidolimab for the treatment of generalised...
GLP-1s support heart attack recovery in rodents by relaxing tight blood vessels
New data from rats and mice now demonstrate that GLP-1s can support heart attack recovery by helping blood vessels relax—literally.
When coronary arteries—which funnel blood to...
Clinical Trials Insight
Preliminary AMT-191 phase 1/2a data shows sustained increases in α-Gal A enzyme activity in patients with Fabry Disease
uniQure has announced updated preliminary safety and exploratory efficacy data from 11 patients in its phase 1/2a trial of AMT-191, an investigational AAV gene therapy...
Vir Biotechnology stock skyrockets 65% on positive prostate cancer treatment trial results
Astellas Pharma and Vir Biotechnology announced they have entered into a global strategic collaboration to advance VIR-5500, an investigational PRO-XTEN® dual-masked CD3 T-cell engager (TCE)...
Triple G candidate drives 20% weight loss in phase 2 trial in China
Novo Nordisk and its Chinese partner have reported up to 19.7% weight loss in patients who took their triple agonist for 24 weeks.
Novo Nordisk...
Results from the eNRGy trial suggest Zenocutuzumab treatment beyond progression demonstrates continued benefit in patients with NRG1+ non-small cell lung cancer
Findings from a post hoc analysis of an eNRGy trial evaluating treatment beyond progression with zenocutuzumab in patients with advanced neuregulin 1 fusion-positive (NRG1+)...
Three‑year rheumatology data demonstrates sustained inflammation control in psoriatic arthritis and axial spondyloarthritis
UCB has announced new three-year data from phase 3 trials, and their open-label extensions, investigating BIMZELX® (bimekizumab-bkzx) in adults with active psoriatic arthritis (PsA) and...
VIDEOS
Pharma in Healthcare
Guardant hits the road with colon cancer blood test
With colon cancer deaths rising among younger adults and millions of eligible Americans skipping their colonoscopies, Guardant Health is taking its Shield blood test...
Wisdom Bioscience establishes scientific advisory board to advance oral cancer diagnostics and screening
Wisdom Bioscience, a biotechnology company pioneering non-invasive oral cancer diagnostics, today announced the formation of its Scientific Advisory Board (SAB) following the close of...
Shining a light on rare diseases: why every discovery matters
Today, on Rare Disease Day, we pause to recognise the millions of individuals and families navigating conditions that too often remain overlooked.
In drug...
New drug accepted for use in NHS Scotland
Johnson & Johnson has announced that the Scottish Medicines Consortium (SMC) has accepted Tremfya® (guselkumab) for use in NHS Scotland for adult patients with...
Alopecia areata market set to expand by 2036, due to the emergence of novel drug classes
The alopecia areata market is expected to grow significantly as awareness of the condition increases, potentially expanding further in the coming years, supported by...
Technology and Automation
Generative AI created to transform drug contracting and accelerate patient access
Lyfegen, a global provider of innovative drug access, contracting and rebate management solutions, has announced its AI Contracting Companion.
This AI solution is designed to...
Collaboration with Google Cloud to accelerate small-molecule discovery using AI agents
A new collaboration is expected to accelerate, scale and advance small-molecule discovery and optimisation for pharmaceutical and agricultural products.
Evogene, a computational chemistry company focused...
AI platform PredictBBB.ai chosen for delivering 94% accuracy in next-gen drug development
Hoth Therapeutics is leveraging Lantern Pharma's breakthrough PredictBBB.ai™ platform, a next-generation artificial intelligence (AI) tool with 94% accuracy in predicting blood-brain barrier permeability.
This adoption positions...
Nanoform granted European commercial cGMP manufacturing licence
Nanoform has received a Commercial cGMP manufacturing licence from FIMEA (Finnish Medicines Agency) for the production and quality control of nanoformed small molecule APIs (Active Pharmaceutical Ingredients).
This license authorises...
Tempris wins ISPE robotics award
Tempris, an innovation leader in wireless in-process product temperature control for freeze-drying, is delighted to announce that it has been presented with the 2025...
Pharma packaging and logistics
Delivery routes expanded and order cut-off times for midwest and west coast customers extended
Smith Drug Company, the industry's largest wholesaler dedicated exclusively to independent retail and long-term care pharmacies, has announced a series of operational enhancements designed...
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered a partnership with...
Samsung Biologics expands US manufacturing capacity with acquisition from GSK
Samsung Biologics has announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100% of Human...
Natix goes to China to enhance manufacturing
To answer the global shortage of high-activity Pancrelipase/Pancreatin Enzybel Pharma 2, Natix has forged a strategic alliance with Deebio, a prominent Chinese manufacturer of...
Innovation to help US pharmacies ship confidently
Cold Chain Technologies (CCT), a global leader in temperature-controlled packaging, is transforming how specialty pharmacies manage cold chain logistics with its innovative digital applications...
Events and conferences
Ilmac Lausanne 2026: start your preparations now
23-24 September 2026 |Beaulieu Lausanne, Switzerland
Held every two years, ILMAC 2026 brings together key stakeholders, decision-makers, and experts from the region and abroad to network, learn...
World Vaccine Congress Europe
19-21 October | Amsterdam, The Netherlands
Pharma Press is excited to announce a partnership with the World Vaccine Congress Europe!
This World-leading vaccine congress will be...
World Vaccine Congress 2026 Washington
30 March – 2 April 2026 | World Vaccine Congress Washington 2026 | Washington D.C.
Visit the world’s leading vaccine event!
The World Vaccine Congress is...
ELRIG Cell & Gene Therapy 2026
9-10 March 2026 | Hinxton Hall Conference Centre, Cambridge, UK
ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, has announced the...
BioTrinity 2026
14-15 April 2026 in London, UK
Welcome to BioTrinity 2026, the 20th edition of OBN's flagship two-day conference for the life sciences industry, designed to...
Funding and Finance
CSL announces expansion of Illinois plasma therapy manufacturing facility
CSL has commenced expansion of its state-of-the-art manufacturing facility in Kankakee, Illinois.
The expansion, a cornerstone of the company's global manufacturing growth strategy and...
Lilly to acquire Orna Therapeutics to advance cell therapies
Eli Lilly and Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo, have agreed for Lilly to acquire Orna.
Orna is advancing a new...
New strategic collaboration to develop new global medicines in oncology and immunology
There is a new strategic collaboration to advance novel medicines in oncology and immunology.
This agreement marks the seventh collaboration between the two companies,...
Bora Pharmaceuticals stock rises after signing $250m five-year manufacturing deal With GSK
Bora Pharmaceuticals, a Taiwan-based international pharmaceutical company, has announced a renewed five-year manufacturing partnership with a pharmaceutical and biotechnology company GSK, extending their collaboration...
BaseLaunch’s biotech venture incubator attracts new partner
BaseLaunch, a platform partnering with scientists and entrepreneurs to launch, fund, and build early biotech ventures, announced today the pharmaceutical giant Pfizer has joined...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
